BING Z CARTER to Aminopyridines
This is a "connection" page, showing publications BING Z CARTER has written about Aminopyridines.
Connection Strength
0.320
-
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia. J Transl Med. 2021 03 21; 19(1):117.
Score: 0.164
-
A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Biomed Pharmacother. 2020 Sep; 129:110390.
Score: 0.156